D012367Chemicals & DrugsD13.444.735.82818470.98264RNA, ViralFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonHerbertBonkovskyHerbert L. Bonkovsky MD36.09032400000000-80.266491000000001707Bonkovsky, HerbertProfessor19747918Shiffman ML, Morishima C, Dienstag JL, Lindsay KL, Hoefs JC, Lee WM, Wright EC, Naishadham D, Everson GT, Lok AS, Di Bisceglie AM, Bonkovsky HL, Ghany MGGastroenterologyShiffman ML, Morishima C, Dienstag JL, Lindsay KL, Hoefs JC, Lee WM, Wright EC, Naishadham D, Everson GT, Lok AS, Di Bisceglie AM, Bonkovsky HL, Ghany MG. Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial. Gastroenterology. 2009 Dec; 137(6):1986-94.Gastroenterology2009-09-10T00:00:002009Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.BiochemistryMicrobiology and ImmunologyWake Forest School of MedicineWernerBischoffWerner E. Bischoff MD, MS, PhD, FSHEA36.09032400000000-80.266491000000001023Bischoff, WernerProfessorDouglasLylesDouglas S. Lyles PhD36.08919100000000-80.26677800000000233Lyles, DouglasProfessorDavidOrnellesDavid A. Ornelles PhD36.08977400000000-80.26684000000000735Ornelles, DavidAssociate Professor26186989O'Brien TR, Pfeiffer RM, Paquin A, Lang Kuhs KA, Chen S, Bonkovsky HL, Edlin BR, Howell CD, Kirk GD, Kuniholm MH, Morgan TR, Strickler HD, Thomas DL, Prokunina-Olsson LJournal of hepatologyO'Brien TR, Pfeiffer RM, Paquin A, Lang Kuhs KA, Chen S, Bonkovsky HL, Edlin BR, Howell CD, Kirk GD, Kuniholm MH, Morgan TR, Strickler HD, Thomas DL, Prokunina-Olsson L. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. J Hepatol. 2015 Nov; 63(5):1103-10.J Hepatol2015-07-15T00:00:002015Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.26386428Bischoff WE, McNall RJ, Blevins MW, Turner J, Lopareva EN, Rota PA, Stehle JRThe Journal of infectious diseasesBischoff WE, McNall RJ, Blevins MW, Turner J, Lopareva EN, Rota PA, Stehle JR. Detection of Measles Virus RNA in Air and Surface Specimens in a Hospital Setting. J Infect Dis. 2016 Feb 15; 213(4):600-3.J Infect Dis2015-09-19T00:00:002015Detection of Measles Virus RNA in Air and Surface Specimens in a Hospital Setting.20ProfessorInternal Medicine, GastroenterologyInternal Medicine, Infectious DiseasesRyanMavesRyan C. Maves MD3072Maves, RyanProfessor33970826Jamil S, Shafazand S, Pasnick S, Carlos WG, Maves R, Cruz CDAmerican journal of respiratory and critical care medicineJamil S, Shafazand S, Pasnick S, Carlos WG, Maves R, Cruz CD. Genetic Variants of SARS-CoV-2: What Do We Know So Far? Am J Respir Crit Care Med. 2021 06 15; 203(12):P30-P32.Am J Respir Crit Care Med2021-06-15T00:00:002021Genetic Variants of SARS-CoV-2: What Do We Know So Far?24210108Furuse Y, Ornelles DA, Cullen BRVirologyFuruse Y, Ornelles DA, Cullen BR. Persistently adenovirus-infected lymphoid cells express microRNAs derived from the viral VAI and especially VAII RNA. Virology. 2013 Dec; 447(1-2):140-5.Virology2013-09-26T00:00:002013Persistently adenovirus-infected lymphoid cells express microRNAs derived from the viral VAI and especially VAII RNA.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professor0.9326690.014578618research area of0.8288750.03090564subject area for